Skip to Main Content

Endocrinology & Metabolism Newsletter

Winter 2023

In this quarterly issue of the Yale Section of Endocrinology and Metabolism, we continue a series highlighting our clinical programs and we look back at some signature accomplishments from the past year.

The Endocrine Neoplasia Program focuses primarily on the care of patients with benign and malignant tumors of the pituitary, thyroid, and adrenal glands. This program is multi-disciplinary and collaborative—we work closely with our colleagues in endocrine surgery, ENT, neurosurgery, pathology, and diagnostic imaging. It is a growing part of our overall practice with six endocrinologists and a new Director, Sachin Majumdar, MD. In addition, we hope to recruit a new faculty member(s) with expertise in clinical research in endocrine neoplasia. Read more about the clinic below.

As I reflect on the year gone by, we at Yale Endocrinology have much to be proud of. I wish I could list all of the faculty’s accomplishments, but I am limited by space. What follows are a but a few highlights.

At Yale, we have always been at the forefront of scientific discoveries and patient care in endocrinology and diabetes, and our faculty and staff are hard at work to push the boundaries of our field even further forward. I look forward to sharing more exciting news in upcoming newsletters.

John Wysolmerski, MD
Professor of Medicine (Endocrinology)
Section Chief, Endocrinology & Metabolism
Department of Internal Medicine, Yale School of Medicine

Latest News

Get RSS Feed